Table 4.
DescriptionI | PheWAS-code | Case | Control | ORII | 95% CI | PFDR |
---|---|---|---|---|---|---|
Positively associated with Asthma PRS | ||||||
Asthma | 495 | 12,963 | 70,020 | 2.71 | 2.41– 3.02 | 3.17×10−65 |
Asthma with exacerbation | 495.2 | 3,043 | 70,020 | 4.72 | 3.74 – 5.95 | 3.39×10−39 |
Emphysema | 508 | 8,276 | 73,217 | 1.78 | 1.56 – 2.05 | 1.22×10−16 |
Chronic obstructive asthma | 495.1 | 1,433 | 70,020 | 3.23 | 2.35 – 4.45 | 4.90×10−13 |
Type 1 diabetes | 250.1 | 4,283 | 69,292 | 1.91 | 1.58 –2.30 | 1.16×10−11 |
Chronic airway obstruction | 496 | 8,056 | 70,020 | 1.56 | 1.36 –1.80 | 5.57×10−10 |
Respiratory failure | 509 | 6,029 | 73,217 | 1.61 | 1.37 – 1.88 | 3.05×10−9 |
Wheezing | 512.1 | 2,234 | 47,495 | 2.17 | 1.68 – 2.82 | 4.37×10−9 |
Diabetes mellitus | 250 | 19,764 | 69,292 | 1.34 | 1.21 – 1.48 | 9.36×10−9 |
Eosinophilic esophagitis | 530.15 | 607 | 62,044 | 3.85 | 2.38 –6.20 | 3.40×10−8 |
Type 2 diabetes | 250.2 | 19,137 | 69,292 | 1.32 | 1.19 – 1.46 | 9.78×10−8 |
Diseases of white blood cells | 288 | 4,694 | 77,026 | 1.61 | 1.35 –1.91 | 1.14×10−7 |
Allergic reaction to food | 930 | 1,688 | 65,842 | 2.25 | 1.66 – 3.04 | 1.49×10−7 |
Negatively associated with Asthma PRS | ||||||
Postmenopausal disorders | 627 | 11,313 | 75,725 | 0.55 | 0.48 – 0.63 | 8.00×10−18 |
Peripheral enthesopathies | 726 | 16,894 | 66,608 | 0.64 | 0.57 –1.71 | 6.31×10−17 |
Hypercholesterolemia | 272.11 | 19,899 | 51,696 | 0.62 | 0.55 –0.69 | 6.55×10−17 |
Hematuria | 593 | 7,632 | 68,213 | 0.55 | 0.48 – 0.64 | 2.50×10−16 |
Benign neoplasm of skin | 216 | 11,233 | 79,947 | 0.63 | 0.56 – 0.71 | 1.86×10−14 |
Disorders of lipid metabolism | 272 | 41,493 | 51,696 | 0.73 | 0.67 –0.80 | 1.04×10−11 |
Hyperlipidemia | 272.1 | 41,299 | 51,696 | 0.73 | 0.67 – 0.80 | 1.11×10−11 |
Disorders of synovium | 727 | 9,291 | 66,608 | 0.64 | 0.56 –1.73 | 3.65×10−11 |
Cataract | 366 | 14,306 | 81,833 | 0.67 | 0.60 –0.76 | 5.14×10−11 |
Carbohydrate transport disorder | 271 | 1,410 | 97,301 | 0.36 | 0.27 – 0.49 | 1.34×10−10 |
Disaccharide malabsorption | 271.3 | 1,302 | 97,301 | 0.35 | 0.25 – 0.48 | 1.40×10−10 |
Elevated prostate specific antigen | 796 | 2,746 | 84,778 | 0.53 | 0.41 – 0.67 | 2.92×10−7 |
Selected results at false discovery rate PFDR<0.05. The complete lists of traits are included in Supplemental Table 5.
OR<1 indicates negative association of trait with asthma PRS